Evidence map›Paper›PMID 23299178›Full record

ArticleEndocrine2013

Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β cell.

Souvik Roy, Satyajit Kumar Metya, Santanu Sannigrahi, Noorjaman Rahaman, Faiqa Ahmed

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 118 citations in OpenAlex.

  1. Article
  2. Article
  3. Oral co-administration ofJournal of virology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Clinical medicine insights. Endocrinology and diabetes · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Impact of the herbal medicine,Frontiers in pharmacology · 2022
    Article
  15. Review
  16. PlantFrontiers in endocrinology · 2022
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Souvik RoyDepartment of Pharmaceutical Technology, NSHM Knowledge Campus, 124 B.L. Saha Road, Kolkata, 700053, West Bengal, India, souvikroy35@gmail.com.
Satyajit Kumar Metya
Santanu Sannigrahi
Noorjaman Rahaman
Faiqa Ahmed
Maulana Abul Kalam Azad University of Technology, West Bengal · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we aimed to investigate the protective effect of ferulic acid at different doses (50 mg/kg alternative day and 50 mg/kg daily) on diabetic rats and to explore the interrelationship between oxidative stress and cytokines correlates with apoptotic events in pancreatic tissue. Male Wistar rats were rendered diabetic by a single intraperitoneal injection of streptozotocin (60 mg/kg body weight). Ferulic acid was administered orally for 8 weeks. At the end of the study, all animals were sacrificed. Blood samples were collected for the biochemical estimations and pancreas was isolated for antioxidant status, histopathological, immunohistochemical, and apoptotic studies. Treatment with ferulic acid to diabetic rats significantly improved blood glucose, serum total cholesterol, triglycerides, creatinine, urea, and albumin levels toward normal. Furthermore, decrement of the elevated lipid peroxidation levels and increment of the reduced superoxide dismutase, catalase, and reduced glutathione enzyme activities in pancreatic tissues were observed in ferulic acid-treated groups. Ferulic acid-treated rats in the diabetic group showed an improved histological appearance. Our data also revealed a significant reduction in the activity of apoptosis using terminal dUTP nick end-labeling and reduced expression of TGF-β1 and IL-1β in the pancreatic β-cell of ferulic acid-treated rats. Treatment with ferulic acid daily doses produced a significant result compared to alternative dose. Collectively our results suggested that ferulic acid acts as a protective agent in diabetic rats by altering oxidative stress, expression of pro-inflammatory cytokines and apoptosis.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalApoptosisCoumaric AcidsCytokinesDiabetes Mellitus, ExperimentalDrug Evaluation, PreclinicalInflammation MediatorsInsulin-Secreting CellsInterleukin-1betaMaleOxidative StressRatsRats, WistarStreptozocinTransforming Growth Factor beta1Anti-Inflammatory Agents, Non-SteroidalCoumaric AcidsCytokinesferulic acidInflammation MediatorsInterleukin-1betaStreptozocinTransforming Growth Factor beta1

Identifiers

PMID23299178
OpenAlexW2150863193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.